81 related articles for article (PubMed ID: 10882277)
1. Gadolinium mesoporphyrin as an MR imaging contrast agent in the evaluation of tumors: an experimental model of VX2 carcinoma in rabbits.
Kim TK; Choi BI; Park SW; Lee W; Han JK; Han MC; Weinmann HJ
AJR Am J Roentgenol; 2000 Jul; 175(1):227-34. PubMed ID: 10882277
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine.
Kim SJ; Moon WK; Choi SH; Chang JM; Cho N
Eur J Radiol; 2012 Aug; 81(8):1751-7. PubMed ID: 21477960
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced MR imaging of VX2 carcinomas after X-irradiation in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent.
Kim YH; Choi BI; Cho WH; Lim S; Moon WK; Han JK; Weinmann HJ; Chang KH
Invest Radiol; 2003 Sep; 38(9):539-49. PubMed ID: 12960523
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MR imaging of bacterial abscess and VX2 carcinoma in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent.
Moon WK; Chang KH; Weinmann HJ; Koh YH; Im JG; Yeon KM; Han MC
AJR Am J Roentgenol; 2000 May; 174(5):1385-90. PubMed ID: 10789800
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: comparison of macromolecular contrast agent and gadopentetate dimeglumine.
Lee JW; Moon WK; Weinmann HJ; Kim SJ; Kim JH; Park SH; Kim TJ; Yoon CJ; Kim YH; Cho EY; Ha SW; Kang WS; Chang KH
Radiology; 2003 Oct; 229(1):132-9. PubMed ID: 14519873
[TBL] [Abstract][Full Text] [Related]
7. Dynamic enhancement features of gadophrin-2 on magnetic resonance imaging: an experimental model of VX2 carcinoma and bacterial abscess in rabbit thigh.
Ju Lee H; Kim IO; Kim TK; Hyung Kim S; Choi JI; Woo Lee J; Kyung Moon W; Choi BI; Chung Han M; Weinmann HJ; Hyun Chang K
Invest Radiol; 2002 Dec; 37(12):663-71. PubMed ID: 12446999
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
9. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor.
Kim TJ; Moon WK; Cha JH; Goo JM; Lee KH; Kim KH; Lee JW; Han JG; Weinmann HJ; Chang KH
Radiology; 2005 Feb; 234(2):423-30. PubMed ID: 15591437
[TBL] [Abstract][Full Text] [Related]
10. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats.
Saeed M; Bremerich J; Wendland MF; Wyttenbach R; Weinmann HJ; Higgins CB
Radiology; 1999 Oct; 213(1):247-57. PubMed ID: 10540668
[TBL] [Abstract][Full Text] [Related]
11. Evolution of VX2 carcinoma in rabbit tibia: magnetic resonance imaging with pathologic correlation.
Choi JA; Kang EY; Kim HK; Song IC; Kim YI; Kang HS
Clin Imaging; 2008; 32(2):128-35. PubMed ID: 18313577
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model.
Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW
Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810
[TBL] [Abstract][Full Text] [Related]
13. Necrotic areas in VX2 carcinoma of rabbits. Correlation of magnetic resonance imaging and pathologic appearance.
Choi BI; Lee DH; Han MC
Invest Radiol; 1993 Jan; 28(1):33-8. PubMed ID: 8425850
[TBL] [Abstract][Full Text] [Related]
14. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
Bremer C; Bankert J; Filler T; Ebert W; Tombach B; Reimer P
J Magn Reson Imaging; 2005 Jun; 21(6):801-8. PubMed ID: 15906334
[TBL] [Abstract][Full Text] [Related]
15. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
17. Half-dose gadolinium-enhanced MR imaging with magnetization transfer technique in brain tumors: comparison with conventional contrast-enhanced MR imaging.
Han D; Chang KH; Han MH; Cho JY; Han SW; Kim HD; Seong SO
AJR Am J Roentgenol; 1998 Jan; 170(1):189-93. PubMed ID: 9423630
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
20. Tumor enhancement using Mn-metalloporphyrin in mice: magnetic resonance imaging and histopathologic correlation.
Nasu H; Takehara Y; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I; Sakahara H
J Magn Reson Imaging; 2004 Aug; 20(2):294-9. PubMed ID: 15269956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
